Wed, January 14, 2009
Tue, January 13, 2009
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009

Adaltis Inc.: Adaltis Announces Change to Board of Directors

  Copy link into your clipboard //business-finance.news-articles.net/content/200 .. ltis-announces-change-to-board-of-directors.html
  Print publication without navigation Published in Business and Finance on , Last Modified on 2009-01-09 11:08:46 by Market Wire
          🞛 This publication is a summary or evaluation of another publication


MONTREAL, QUEBEC--(Marketwire - Jan. 9, 2009) - Adaltis Inc. (TSX:ADS), an international in vitro diagnostic company, announced the resignation of Mr. Kwok Man Leung from the Board of Directors of the Company and as a member of the Audit Committee, effective December 31, 2008. The Board wishes to thank Mr. Kwok for his commitment to the Company.

About Adaltis Inc.

Adaltis is an international in vitro diagnostic company with a mission to become a leading provider of in vitro diagnostic products in emerging markets, with a particular focus on China.

With the strategic advantage of its "state of the art" reagent manufacturing facility located in Shanghai, China, a complete IVD product offering targeting emerging markets, and a strong international sales and distribution platform, Adaltis is able to manufacture high-quality products in a low-cost GMP environment, in order to service existing markets in Europe, while providing a platform to penetrate the high-growth Chinese in vitro diagnostic market.

Adaltis is headquartered in Montreal, with offices in China, Hong Kong, Italy, India and Mexico.